Storage and handling
Store at 20° to 25° C (68° to 77° F)
Store at 20° to 25° C (68° to 77° F)
Store at 20° to 25° C (68° to 77° F)
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| PHENYLEPHRINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71384-650-01 | 2022-01-28 | C162847 | 48780-1 | 9d75b9d0-ab61-f424-e053-dadaa90a57ce | 6e112b67-58d4-7f32-e053-2a91aa0a8cc5 |
| 71384-650-01 | 2020-02-12 | C162847 | 48780-1 | 9d75b9d0-ab61-f424-e053-dadaa90a57ce | 6e112b67-58d4-7f32-e053-2a91aa0a8cc5 |
| 71384-650-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-ab61-f424-e053-dadaa90a57ce | 6e112b67-58d4-7f32-e053-2a91aa0a8cc5 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71384-650-01 | Phenyl-Lido | 1 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 1 | 2 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71384-650-01 | ML - Milliliter | 71384-650 | e83a7844-2667-45f5-bd46-8088dc80c0cc | 1 | 2018-11-06 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 71384-650 | 71384-650-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LIDOCAINE HYDROCHLORIDE | V13007Z41A | ACTIR |
| PHENYLEPHRINE HYDROCHLORIDE | 04JA59TNSJ | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9e647045-a8b6-4f3e-e053-2995a90a7a0b | 6e112b67-58d4-7f32-e053-2a91aa0a8cc5 | 2020-02-12 | 9e647045-a8b6-4f3e-e053-2995a90a7a0b 6e112b67-58d4-7f32-e053-2a91aa0a8cc5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.